Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in DenmarkAnne Troldborg, Bent Deleuran, Lauren Remkus et al.|Lupus|2024Cited by 7